Malin Corporation | MLC - Ativo Circulante





Ativo Circulante Alterar Data
Akebia Therapeutics USD 229.55M 13.93M 2026-06
Alaunos Therapeutics USD 970K 1.02M 2026-03
ALKERMES USD 1.52B 164.26M 2026-06
Avita Medical AUD 35.49M 760K 2025-12
Dianthus Therapeutics USD 897.54M 222.37M 2026-06
Eurofins Scientific SE EUR 2.81B 161M 2026-06
Ionis Pharmaceuticals USD 2.49B 446.73M 2026-06
IQVIA Holdings USD 6.23B 6M 2026-06
Lonza CHF 8B 3.41B 2025-12
Malin Corporation EUR 62.6M 26.7M 2024-12
Moderna USD 5.82B 45M 2026-06
Organon & Co USD 5.11B 179M 2026-06
Ovoca Bio EUR 2.07M 510K 2025-12
Revvity USD 2.3B 169.4M 2026-06
Tectonic Therapeutic USD 239.89M 17.47M 2026-03
Viatris USD 10.06B 861.1M 2026-06
Xeris Pharmaceuticals USD 274.76M 23.08M 2026-06